Cargando…
Clinical experience of tocilizumab treatment among a cohort of patients with COVID-19 infection from Western India
BACKGROUND: Initiation of tocilizumab (TCZ) treatment in patients with coronavirus disease 2019 (COVID-19) during the early phases of cytokine storm is crucial. This study evaluated the clinical experience of TCZ use in the treatment of patients with COVID-19. METHODS: This retrospective observation...
Autores principales: | Surana, Prince D., Nayak, Rupesh, Sheikh, Arif, Haldankar, Pradnya, Kale, Jyoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930122/ https://www.ncbi.nlm.nih.gov/pubmed/35309657 http://dx.doi.org/10.4103/jfmpc.jfmpc_817_21 |
Ejemplares similares
-
A single-center experience in use of tocilizumab in COVID-19 pneumonia in India
por: Joshi, Aditya, et al.
Publicado: (2021) -
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India
por: Dravid, Ameet, et al.
Publicado: (2021) -
Tocilizumab for the treatment of systemic onset JIA: a single centre experience from India
por: Sawhney, Sujata, et al.
Publicado: (2012) -
Obstructive sleep apnea domains: Knowledge, attitude and practice results of dentists from a dental college in India
por: Kale, Sonal Sadashiv, et al.
Publicado: (2020) -
Study of dry eye disease in type 2 diabetes mellitus and its association with diabetic retinopathy in Western India
por: Mansuri, Farhad, et al.
Publicado: (2023)